Area of research
Epidemiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Pituitary Gland Disorders and Treatments, Neuroblastoma Research and Treatments, and Lung Cancer Research Studies.
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.
Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort.
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications.
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET).
Emerging therapies for advanced insulinomas and glucagonomas.
Efficacy of denosumab monotherapy among adults with Langerhans cell histiocytosis: A prospective clinical trial.
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey.
Pancreatic metastases in patients with neuroendocrine neoplasms: A <scp>multi‐centre</scp> cohort study
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms.
Adrenocortical dysfunction in rheumatoid arthritis: Α narrative review and future directions.
Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement.
Prevalence of the <i>BRAF</i> <sup>V600E</sup> mutation in Greek adults with Langerhans cell histiocytosis.
Plasma Polyamines as an Additional to Imaging Biomarker in MEN1 Patients With Duodenopancreatic Neuroendocrine Tumors.
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Clinical Utility of <sup>18</sup>F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis.
Surufatinib - a novel oral agent for neuroendocrine tumours.
Diabetes insipidus secondary to sellar/parasellar lesions.
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study.
Surgical treatment outcome of primary aldosteronism assessed using new modified diagnostic tests.
Inherited/Genetically-Associated Pheochromocytoma/ Paraganglioma Syndromes and COVID-19.
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.
A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood.